Institutional members access full text with Ovid®

Share this article on:

The Role of Imaging in Hepatocellular Carcinoma: The Present and Future

Davarpanah, Amir H. MD; Weinreb, Jeffrey C. MD, FACR

Journal of Clinical Gastroenterology: July 2013 - Volume 47 - Issue - p S7–S10
doi: 10.1097/MCG.0b013e31827f0d3d

Imaging plays an important role in diagnosis and management of patients with hepatocellular carcinoma (HCC). Although ultrasound is the main surveillance imaging tool for HCC, dynamic contrast-enhanced computed tomography (CT) and magnetic resonance imaging (MRI) are used primarily for diagnosis and staging of HCC. Recent advances in both CT and MRI technology have led to a decrease in ionizing radiation exposure and improved capabilities for evaluation of HCC, including, dynamic contrast-enhanced CT and MRI, perfusion CT and MRI, dual-energy CT, radiation dose reduction strategies, diffusion-weighted imaging, MR elastography, iron and fat quantification, and intravenous hepatobiliary contrast agents.

Department of Radiology, Yale University School of Medicine, New Haven, CT

The authors declare that they have nothing to disclose.

Reprints: Jeffrey C. Weinreb, MD, FACR, Department of Radiology, Yale University School of Medicine, 333 Cedar St, P.O. Box 208042, New Haven, CT 06520-8042 (e-mail:

© 2013 by Lippincott Williams & Wilkins